A compound that inhibits replication of the dengue virus in mammals was similarly effective in mosquitoes consuming it via blood, reducing transmissibility.
A new vaccine targeting mosquito saliva proteins proved safe and prompted a strong immune response in humans, moving scientists one step closer to halting the transmission of all mosquito-borne pathogens.